Literature DB >> 19400500

A patient with intractable posthypoxic myoclonus (Lance-Adams syndrome) treated with sodium oxybate.

R Arpesella1, C Dallocchio, C Arbasino, R Imberti, R Martinotti, S J Frucht.   

Abstract

Posthypoxic myoclonus is a rare and devastating complication of near-fatal cardiopulmonary arrest. Despite treatment with available anti-myoclonic agents, some patients may recover cognitively but remain completely disabled by severe myoclonus. We report a 16-year-old patient with severe treatment-refractory posthypoxic myoclonus, which improved markedly with administration of the drug sodium oxybate.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19400500     DOI： 10.1177/0310057X0903700214

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN： 0310-057X            Impact factor:   1.669


  9 in total

1.  An open-label study of sodium oxybate in Spasmodic dysphonia.

Authors:  Anna F Rumbach; Andrew Blitzer; Steven J Frucht; Kristina Simonyan
Journal:  Laryngoscope       Date:  2016-11-03       Impact factor: 3.325

2.  Add-on perampanel in Lance-Adams syndrome.

Authors:  Bernhard J Steinhoff; Matthias Bacher; Christoph Kurth; Anke M Staack; Reinhold Kornmeier
Journal:  Epilepsy Behav Case Rep       Date:  2016-06-01

Review 3.  Medical treatment of dystonia.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2016-12-19

Review 4.  Post-hypoxic Myoclonus: Current Concepts, Neurophysiology, and Treatment.

Authors:  Harsh V Gupta; John N Caviness
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-09-17

5.  Increasing Evidence for the Use of Sodium Oxybate in Multi-Drug-Resistant Lance-Adams Syndrome.

Authors:  Giulietta M Riboldi; Steven J Frucht
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-06-17

Review 6.  Myoclonus: Pathophysiology and Treatment Options.

Authors:  Ariel Levy; Robert Chen
Journal:  Curr Treat Options Neurol       Date:  2016-05       Impact factor: 3.972

7.  Levatiracetam for the management of Lance-Adams syndrome.

Authors:  Faik Ilik; Mustafa Kemal Ilik; Ilker Cöven
Journal:  Iran J Child Neurol       Date:  2014

8.  A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity.

Authors:  Kristina Simonyan; Steven J Frucht; Andrew Blitzer; Azadeh Hamzehei Sichani; Anna F Rumbach
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

9.  Alcohol-Responsive Hyperkinetic Movement Disorders-a Mechanistic Hypothesis.

Authors:  Steven J Frucht; Giulietta M Riboldi
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.